Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty
Background The purpose was to report mid-term to long-term clinical outcomes in a multicentre series of patients who received stemless total shoulder arthroplasty (TSA). The hypothesis was that stemless TSA would be a safe and effective treatment with satisfactory clinical outcomes. Methods Authors...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-03-01
|
| Series: | Journal of Shoulder and Elbow Arthroplasty |
| Online Access: | https://doi.org/10.1177/24715492231163055 |
| _version_ | 1827986209959313408 |
|---|---|
| author | Thierry Authom MD Tristan Lascar MD Hassan Wahab MD Antoine Gournay MD Emmanuel Beaudouin MD Jacobus H Muller PhD Mo Saffarini M.Eng, MBA, FRSM Geoffroy Nourissat MD |
| author_facet | Thierry Authom MD Tristan Lascar MD Hassan Wahab MD Antoine Gournay MD Emmanuel Beaudouin MD Jacobus H Muller PhD Mo Saffarini M.Eng, MBA, FRSM Geoffroy Nourissat MD |
| author_sort | Thierry Authom MD |
| collection | DOAJ |
| description | Background The purpose was to report mid-term to long-term clinical outcomes in a multicentre series of patients who received stemless total shoulder arthroplasty (TSA). The hypothesis was that stemless TSA would be a safe and effective treatment with satisfactory clinical outcomes. Methods Authors retrospectively reviewed records of 62 stemless TSAs implanted between March 2013 and December 2014. Six were excluded because they had fractures or muscular impairment, which left 56: primary osteoarthritis (n = 49), rheumatoid arthritis (n = 4), avascular necrosis (n = 1), or glenoid dysplasia (n = 2). Outcomes were absolute Constant Score (CS), age-/sex-adjusted CS, and the American Shoulder and Elbow Surgeons (ASES) score. Proportions of patients that achieved substantial clinical benefits for absolute CS and ASES scores were determined. Results Of the 56 patients, 8 (14%) died (unrelated to TSA), 5 (9%) were lost to follow-up, and 2 (4%) refused participation. One patient was reoperated for infection with implant removal (excluded from analysis), and one for periprosthetic fracture without implant removal. At 7.6 ± 0.5 years (range 6.8-9.3), the remaining 40 patients, aged 71.0 ± 8.5 years, achieved net improvements of 40.7 ± 15.8 (CS), 62%±23% (age-/sex-adjusted CS), and 59.7 ± 16.4 (ASES). Of patients with complete absolute CS (n = 37) and ASES score (n = 28), respectively, 33 (89%) and 27 (96%) achieved substantial clinical benefits. Conclusions Stemless TSA yields improvements in functional outcomes at mid-term to long-term that exceed the substantial clinical benefits of the absolute CS and ASES score at a mean follow-up of 7.6 years. Although the findings of this study revealed low complications and revision rates, more studies are needed to confirm long-term benefits of stemless TSA. Level of evidence IV, case series. |
| first_indexed | 2024-04-09T23:28:24Z |
| format | Article |
| id | doaj.art-35c9f1323ff34e4b8f3b6a2cbd25933b |
| institution | Directory Open Access Journal |
| issn | 2471-5492 |
| language | English |
| last_indexed | 2024-04-09T23:28:24Z |
| publishDate | 2023-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of Shoulder and Elbow Arthroplasty |
| spelling | doaj.art-35c9f1323ff34e4b8f3b6a2cbd25933b2023-03-21T07:33:18ZengSAGE PublishingJournal of Shoulder and Elbow Arthroplasty2471-54922023-03-01710.1177/24715492231163055Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder ArthroplastyThierry Authom MD0Tristan Lascar MD1Hassan Wahab MD2Antoine Gournay MD3Emmanuel Beaudouin MD4Jacobus H Muller PhD5Mo Saffarini M.Eng, MBA, FRSM6Geoffroy Nourissat MD7 Clinique Saint Charles, Lyon, France Centre Hospitalier Princesse Grace, Monaco Clinique St Léonard, Trélazé, France Clinique St Léonard, Trélazé, France CHMS Chambery, Chambéry, France ReSurg S.A., Nyon, Switzerland ReSurg S.A., Nyon, Switzerland Clinique des Maussins, Ramsay Santé, Paris, FranceBackground The purpose was to report mid-term to long-term clinical outcomes in a multicentre series of patients who received stemless total shoulder arthroplasty (TSA). The hypothesis was that stemless TSA would be a safe and effective treatment with satisfactory clinical outcomes. Methods Authors retrospectively reviewed records of 62 stemless TSAs implanted between March 2013 and December 2014. Six were excluded because they had fractures or muscular impairment, which left 56: primary osteoarthritis (n = 49), rheumatoid arthritis (n = 4), avascular necrosis (n = 1), or glenoid dysplasia (n = 2). Outcomes were absolute Constant Score (CS), age-/sex-adjusted CS, and the American Shoulder and Elbow Surgeons (ASES) score. Proportions of patients that achieved substantial clinical benefits for absolute CS and ASES scores were determined. Results Of the 56 patients, 8 (14%) died (unrelated to TSA), 5 (9%) were lost to follow-up, and 2 (4%) refused participation. One patient was reoperated for infection with implant removal (excluded from analysis), and one for periprosthetic fracture without implant removal. At 7.6 ± 0.5 years (range 6.8-9.3), the remaining 40 patients, aged 71.0 ± 8.5 years, achieved net improvements of 40.7 ± 15.8 (CS), 62%±23% (age-/sex-adjusted CS), and 59.7 ± 16.4 (ASES). Of patients with complete absolute CS (n = 37) and ASES score (n = 28), respectively, 33 (89%) and 27 (96%) achieved substantial clinical benefits. Conclusions Stemless TSA yields improvements in functional outcomes at mid-term to long-term that exceed the substantial clinical benefits of the absolute CS and ASES score at a mean follow-up of 7.6 years. Although the findings of this study revealed low complications and revision rates, more studies are needed to confirm long-term benefits of stemless TSA. Level of evidence IV, case series.https://doi.org/10.1177/24715492231163055 |
| spellingShingle | Thierry Authom MD Tristan Lascar MD Hassan Wahab MD Antoine Gournay MD Emmanuel Beaudouin MD Jacobus H Muller PhD Mo Saffarini M.Eng, MBA, FRSM Geoffroy Nourissat MD Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty Journal of Shoulder and Elbow Arthroplasty |
| title | Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty |
| title_full | Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty |
| title_fullStr | Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty |
| title_full_unstemmed | Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty |
| title_short | Mid-Term to Long-Term Follow-Up of Stemless Anatomic Total Shoulder Arthroplasty |
| title_sort | mid term to long term follow up of stemless anatomic total shoulder arthroplasty |
| url | https://doi.org/10.1177/24715492231163055 |
| work_keys_str_mv | AT thierryauthommd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT tristanlascarmd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT hassanwahabmd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT antoinegournaymd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT emmanuelbeaudouinmd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT jacobushmullerphd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT mosaffarinimengmbafrsm midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty AT geoffroynourissatmd midtermtolongtermfollowupofstemlessanatomictotalshoulderarthroplasty |